Apontis Pharma AG

Director's Dealing • May 13, 2024

News Details

Directors’ Dealings | 13 May 2024 07:30

APONTIS PHARMA AG: Thomas Zimmermann, buy

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

13.05.2024 / 07:30 CET/CEST

The issuer is solely responsible for the content of this announcement.

1. Details of the person discharging managerial responsibilities / person closely associated

a) Name

Title:
First name:	Thomas
Last name(s):	Zimmermann

2. Reason for the notification

a) Position / status

Position:	Chief Financial Officer

b) Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name

APONTIS PHARMA AG

b) LEI

894500ETO1J6MR8PDF91

4. Details of the transaction(s)

a) Description of the financial instrument, type of instrument, identification code

Type:	Share
ISIN:	DE000A3CMGM5

b) Nature of the transaction

Acquisition

c) Price(s) and volume(s)

Price(s)	Volume(s)
8.4400 EUR	10,128.0000 EUR

d) Aggregated information

Price	Aggregated volume
8.4400 EUR	10,128.0000 EUR

e) Date of the transaction

2024-05-08; UTC+2

f) Place of the transaction

Name:	Tradegate
MIC:	TGAT

---

13.05.2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Archive at www.eqs-news.com

---

Language:	English
Company:	APONTIS PHARMA AG
	Alfred-Nobel-Str. 10
	40789 Monheim
	Germany
Internet:	https://apontis-pharma.de/

End of News	EQS News Service